Renal amyloidosis diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}[[User:Okamal|Omer Kamal, M.D.]] [Mailto:okamal@bidmc.harvard.edu| <nowiki>[2]</nowiki>] | {{CMG}}; {{AE}}[[User:Okamal|Omer Kamal, M.D.]] [Mailto:okamal@bidmc.harvard.edu| <nowiki>[2]</nowiki>] | ||
== Overview == | == Overview == | ||
Renal biopsy is the gold standard test for the diagnosis of renal amyloidosis | |||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
Renal biopsy is the gold standard test for the diagnosis of renal amyloidosis.<ref name="pmid2912466">{{cite journal |vauthors=Duston MA, Skinner M, Meenan RF, Cohen AS |title=Sensitivity, specificity, and predictive value of abdominal fat aspiration for the diagnosis of amyloidosis |journal=Arthritis Rheum. |volume=32 |issue=1 |pages=82–5 |date=January 1989 |pmid=2912466 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
Latest revision as of 18:58, 8 August 2018
|
Renal amyloidosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Template:Renal amyloidosis On the Web |
|
American Roentgen Ray Society Images of Renal amyloidosis diagnostic study of choice |
|
Risk calculators and risk factors for Renal amyloidosis diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D. [2]
Overview
Renal biopsy is the gold standard test for the diagnosis of renal amyloidosis
Diagnostic Study of Choice
Renal biopsy is the gold standard test for the diagnosis of renal amyloidosis.[1]